S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
The #1 Crypto for 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Biden’s $374B Giveaway Into This Sector (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
Healthcare Takes A Big Step Forward With The Help Of AI (Ad)
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
The #1 Crypto for 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Biden’s $374B Giveaway Into This Sector (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
Healthcare Takes A Big Step Forward With The Help Of AI (Ad)
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
The #1 Crypto for 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Biden’s $374B Giveaway Into This Sector (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
Healthcare Takes A Big Step Forward With The Help Of AI (Ad)
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
The #1 Crypto for 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Biden’s $374B Giveaway Into This Sector (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
Healthcare Takes A Big Step Forward With The Help Of AI (Ad)
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
Free Trial
NASDAQ:CINC

CinCor Pharma (CINC) Stock Price, News & Analysis

→ Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad)
Free CINC Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$29.02
▼
$29.35
50-Day Range
$28.73
▼
$29.56
52-Week Range
$10.53
▼
$43.15
Volume
6.35 million shs
Average Volume
818,447 shs
Market Capitalization
$1.27 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
CINC stock logo

About CinCor Pharma Stock (NASDAQ:CINC)

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts.

CINC Stock News Headlines

March 22, 2024 | thestreet.com
CinCor Pharma Inc.
December 12, 2023 | bbc.com
Purdue Pharma to plead guilty in $8bn opioid settlement
April 19, 2024 | Crypto Swap Profits (Ad)
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
December 6, 2023 | bizjournals.com
Impel Pharmaceuticals hit by another C-suite departure
December 4, 2023 | marketwatch.com
Catalyst Pharma's Finance Chief to Retire, Be Succeeded by Impel's CFO
November 4, 2023 | ca.finance.yahoo.com
Small Pharma Inc. (DMT.V)
October 20, 2023 | msn.com
Abivax Readies $250 Million U.S. IPO For Drug Pipeline
June 9, 2023 | uk.finance.yahoo.com
Diabetic Kidney Disease Global Market Report 2023
April 19, 2024 | Crypto Swap Profits (Ad)
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
May 11, 2023 | marketwatch.com
8-K: IMPEL PHARMACEUTICALS INC
May 9, 2023 | finance.yahoo.com
Chronic Kidney Disease Pipeline Booms as 90+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
April 25, 2023 | finanznachrichten.de
Financial Results for the Year Ended 31 December -3-
March 16, 2023 | reuters.com
NASDAQ Biotechnology Index
March 13, 2023 | finance.yahoo.com
HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors
February 21, 2023 | finance.yahoo.com
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
February 9, 2023 | msn.com
As demand for Covid vaccines falls, AstraZeneca lines up 'blockbuster' products for 2023
January 24, 2023 | marketwatch.com
ADRs End Higher; AstraZeneca, Barclays Trade Actively
January 23, 2023 | msn.com
Britain's AstraZeneca launches tender offer for CinCor Pharma
January 23, 2023 | finance.yahoo.com
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
January 12, 2023 | msn.com
Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023 | seekingalpha.com
AstraZeneca Is Acquiring CinCor Pharma: Market Values Interesting CVR At $3.21
January 11, 2023 | bizjournals.com
AstraZeneca reaches deal to buy CinCor Pharma for up to $1.8 billion
January 10, 2023 | finance.yahoo.com
AstraZeneca Stock Nabs Brief Breakout After $1.8 Billion CinCor Buyout
January 10, 2023 | marketwatch.com
EQUITY ALERT: The M&A Class Action Firm Announces the Investigation of CinCor Pharma, Inc - CINC
January 10, 2023 | finance.yahoo.com
AstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyout
January 9, 2023 | msn.com
AstraZeneca buying hypertension-focused CinCor for up to $1.8 billion
January 9, 2023 | finance.yahoo.com
AstraZeneca to Buy CinCor Pharma for Up to $1.8 Billion
See More Headlines
Receive CINC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CinCor Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CINC
CUSIP
N/A
CIK
1868734
Web
www.cincor.com
Phone
844-531-1834
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($17.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-50,370,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.03%
Return on Assets
-27.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
51.96
Quick Ratio
51.96

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.74) per share
Price / Book
-16.70

Miscellaneous

Outstanding Shares
43,760,000
Free Float
36,937,000
Market Cap
$1.27 billion
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Marc M. P. de Garidel (Age 64)
    CEO & Director
    Comp: $776.86k
  • Dr. Mason W. Freeman M.D. (Age 71)
    Chief Medical Officer
    Comp: $285.56k
  • Ms. Catherine Pearce DHSc (Age 46)
    M.B.A., MBA, Co-Founder & COO
  • Mr. Michael W. Kalb CPA (Age 51)
    Exec. VP, CFO & Principal Accounting Officer
  • Ms. Ida Hatoum
    Sr. VP and Head of People, Talent & Culture
  • Hema Keshava
    Corp. Controller

Key Competitors

View All Competitors

CINC Stock Analysis - Frequently Asked Questions

When did CinCor Pharma IPO?

CinCor Pharma (CINC) raised $176 million in an IPO on the week of November 7th 2022. The company issued 11,000,000 shares at $15.00-$17.00 per share.

This page (NASDAQ:CINC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The “Perfect Storm” for Gold
Gold Safe Exchange
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Your Money is Not Safe
American Alternative
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research